ArticleBMC urology2023

Seminal papers in urology: maintenance Bacillus Calmette-Guerin (BCG) immunotherapy for recurrent Ta, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized southwest oncology group study (SWOG-8507).

Jake Tempo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.